e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Pathogenesis and risk of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung diseases infection and risk of lung cancer
I. Pavlovska, N. Orovcanec, B. Tausanova, B. Zafirova (Skopje, Fyrom)
Source:
Annual Congress 2013 –Pathogenesis and risk of lung cancer
Session:
Pathogenesis and risk of lung cancer
Session type:
Thematic Poster Session
Number:
4504
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Pavlovska, N. Orovcanec, B. Tausanova, B. Zafirova (Skopje, Fyrom). Lung diseases infection and risk of lung cancer. Eur Respir J 2013; 42: Suppl. 57, 4504
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Relationship between risk factors for lung cancer and tumor size
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Accelerated lung function decline increases the risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Epidemiological changes of patients with lung cancer over Years
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013
Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Survival in patients with lung cancer, with and without self reported cardiovascular disease the HUNT study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Relationship between lung cancer and chronic obstructive pulmonary disease
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
LATE-BREAKING ABSTRACT: Cardio vascular disease and the risk of lung cancer, the HUNT study
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Radiation pneumonitis; early diagnosis and associated factors
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Lung cancer in never smokers. A survival analysis in a radon prone area
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept